ESC Premium Access

Rate of very late stent thrombosis differs between drug-eluting stents: a 5-year pooled landmark analysis of the SORT OUT III, IV, and V trials

Congress Presentation

About the speaker

Professor Michael Maeng

Aarhus University Hospital, Aarhus (Denmark)
2 presentations
0 follower

8 more presentations in this session

Five-year outcomes of bifurcation stenting: insights from the SYNTAX trial

Speaker: Doctor M. Spaziano (Montreal, CA)


Burden and causes of rehospitalisations following coronary artery bypass grafting: a nationwide study

Speaker: Mr J. Butt (Copenhagen, DK)


Bilateral internal mammary artery in situ versus Y-graft: mid-term results

Speaker: Miss F. Saraiva (Porto, PT)


Adherence to cardiac surgical waitlist guidelines is a poor predictor of cardiac surgery waitlist mortality

Speaker: Doctor J. Senaratne (Edmonton, CA)


Comparative efficacy and safety of novel biodegradable polymer sirolimus-eluting stents versus permanent polymer everolimus-eluting stents at 5-year follow-up

Speaker: Doctor R. Colleran (Dublin, IE)


Access the full session

Optimised myocardial revascularisation strategies

Speakers: Professor M. Maeng, Doctor M. Spaziano, Mr J. Butt, Miss F. Saraiva, Doctor J. Senaratne...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb